Urbandoor Lifecare Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 24-07-2024
- Paid Up Capital ₹ 0.50 M
as on 24-07-2024
- Company Age 6 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 121.45%
(FY 2023)
- Profit 19.89%
(FY 2023)
- Ebitda 14.18%
(FY 2023)
- Net Worth -33.72%
(FY 2023)
- Total Assets 0.18%
(FY 2023)
About Urbandoor Lifecare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Adil Khan and Faisal Khan serve as directors at the Company.
- CIN/LLPIN
U85300UP2018PTC106198
- Company No.
106198
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Jul 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Urbandoor Lifecare?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Adil Khan  | Director | 12-Jul-2018 | Current |
| Faisal Khan | Director | 12-Jul-2018 | Current |
Financial Performance of Urbandoor Lifecare.
Urbandoor Lifecare Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 121.45% increase. The company also saw a substantial improvement in profitability, with a 19.89% increase in profit. The company's net worth observed a substantial decline by a decrease of 33.72%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Urbandoor Lifecare?
In 2023, Urbandoor Lifecare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ziko Pharmaceuticals Private LimitedActive 7 years 6 monthsAdil Khan and Faisal Khan are mutual person
Urbandoor Infratech Private LimitedActive 10 years 1 monthAdil Khan and Faisal Khan are mutual person
Haxtax Insurance Broking Private LimitedActive 3 years 8 monthsAdil Khan and Faisal Khan are mutual person
Haxtax Management Consultancy Private LimitedActive 7 years 4 monthsAdil Khan and Faisal Khan are mutual person
Urbandoor Resorts Private LimitedActive 7 years 7 monthsAdil Khan and Faisal Khan are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Urbandoor Lifecare?
Unlock and access historical data on people associated with Urbandoor Lifecare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Urbandoor Lifecare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Urbandoor Lifecare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
